Incorporating uncertainty in aggregate burden of disease measures: An example of dalys-averted by a smoking cessation campaign in the UK

Journal of Epidemiology and Community Health

Volumn 65, Issue 9, 2011, Pages 751-756

  de Vocht, Frank ^a   Higgerson, James ^a   Oliver, Kathryn ^a   Verma, Arpana ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE STUDY; DISEASE INCIDENCE; FUTURE PROSPECT; HEALTH POLICY; HEALTH RISK; MORBIDITY; MORTALITY; PRIORITIZATION; PUBLIC HEALTH; SMOKING; UNCERTAINTY ANALYSIS;

ADULT; ARTICLE; COST OF ILLNESS; EPIDEMIOLOGY; FINANCIAL MANAGEMENT; HEART MUSCLE ISCHEMIA; HUMAN; LIFE EXPECTANCY; MASS MEDIUM; METHODOLOGY; MIDDLE AGED; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; SMOKING; SMOKING CESSATION; STATISTICS; UNCERTAINTY; UNITED KINGDOM;

ADULT; COST OF ILLNESS; EPIDEMIOLOGIC METHODS; GREAT BRITAIN; HUMANS; LIFE EXPECTANCY; MARKETING OF HEALTH SERVICES; MASS MEDIA; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; SMOKING; SMOKING CESSATION; UNCERTAINTY;

UNITED KINGDOM;

EID: 80052623510     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2010.119842     Document Type: Article

References (43)

1. Heller RF. Evidence for Public Health. 1st edn. Oxford, United Kingdom: Oxford University Press, 2006:1-138.
2. Lapostolle A, Lefranc A, Gremy I, et al. Sensitivity analysis in summary measure of population health in France. Eur J Public Health 2008;18:195-200.
3. Knol AB, Petersen AC, van der Sluijs JP, et al. Dealing with uncertainties in environmental burden of disease assessment. Environ Health 2009;8:21.
4. Heller RF, Dobson AJ. Disease impact number and population impact number: population perspectives to measures of risk and benefit. BMJ 2000;321:950-3.
5. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994;72:429-45.
6. Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 1994;72:495-509.
7. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42.
8. Stouthard M, Essink-Bot M, Bonsel G. Disability weights for diseases. Eur J Public Health 2000;10:24-30.
9. Anand S, Hanson K. Disability-adjusted life years: a critical review. J Health Econ 1997;16:685-702.
10. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, et al, eds. Global Burden of Disease and Risk Factors. New York: Oxford University Press; The World Bank, 2006:45-240.
11. Murray CJ, Lopez AD. The global burden of disease study. In: Warrell D, Cox T, Firth J, et al, eds. Oxford Textbook of Medicine. 4th edn. Oxford: Oxford University Press, 2003:45-51.
12. Fernández de Larrea-Baz N, Alvarez-Mart́i{dotless}n E, Morant-Ginestar C, et al. Burden of disease due to cancer in Spain. BMC Public Health 2009;9:42.
13. Dodhia H, Phillips K. Measuring burden of disease in two inner London boroughs using disability adjusted life years. J Public Health 2008;30:313-21.
14. Chisholm D, Rehm J, Van Ommeren M, et al. Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. J Stud Alcohol 2004;65:782-93.
15. Lai T, Habicht J, Reinap M, et al. Costs, health effects and cost-effectiveness of alcohol and tobacco control strategies in Estonia. Health Policy 2007;84: 75-88.
16. Hansen KS, Chapman G. Setting priorities for the health care sector in Zimbabwe using cost-effectiveness analysis and estimates of the burden of disease. Cost Eff Resour Alloc 2008;6:14.
17. WHO. World Health Report 2002: Reducing Risks, Promoting Healthy Life. France: World Health Organization, 2002.
18. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994;3:95-104.
19. Manning WG, Fryback DG, Weinstein MC. Reflecting uncertainty in costeffectiveness analysis. In: Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
20. Walker D, Fox-Rushby J. Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis. Health Policy Plan 2001;16:435-43.
21. Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan 2001;16:326-31.
22. Steenland K, Greenland S. Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer. Am J Epidemiol 2004;160:384-92.
23. Critchfield GC, Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making 1986;6:85-92.
24. Doubilet P, Begg CB, Weinstein MC, et al. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985;5:157-77.
25. Ades AE, Claxton K, Sculpher M. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. Health Econ 2006;15:373-81.
26. Lord J, Asante MA. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis. Health Econ 1999;8:323-33.
27. Claxton K, Sculpher M, McCabe C, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005;14:339-47.
28. Glickman ME, van Dyk DA. Basic Bayesian methods. Methods Mol Biol 2007;404:319-38.
29. R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.
30. Ryan R, Majeed A. Prevalence of ischaemic heart disease and its management with statins and aspirin in general practice in England and Wales, 1994 and 1998. Health Stat Q 2001;12:34-9.
31. Lampe FC, Whincup PH, Wannamethee SG, et al. The natural history of prevalent ischaemic heart disease in middle-aged men. Eur Heart J 2000;21:1052-62.
32. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004;(1):CD003041.
33. McVey D, Stapleton J. Can anti-smoking television advertising affect smoking behaviour? controlled trial of the Health Education Authority for England's anti-smoking TV campaign. Tob Control 2000;9:273-82.
34. Gilks W, Richardson S, Spiegelhalter D. Markov Chain Monte Carlo in Practice. 1st edn. London: Chapman & Hall/CRC, 1996:1-481.
35. Gelman A, Carlin J, Stern H, et al. Bayesian Data Analysis. 2nd edn. Boca Raton: CRC Press, 2004:1-609.
36. Budke CM, Jiamin Q, Zinsstag J, et al. Use of disability adjusted life years in the estimation of the disease burden of echinococcosis for a high endemic region of the Tibetan plateau. Am J Trop Med Hyg 2004;71:56-64.
37. Norman R, Mathee A, Barnes B, et al. Estimating the burden of disease attributable to lead exposure in South Africa in 2000. S Afr Med J 2007;97(8 Pt 2):773-80.
38. Schneider M, Norman R, Parry C, et al. Estimating the burden of disease attributable to alcohol use in South Africa in 2000. S Afr Med J 2007;97(8 Pt 2):664-72.
39. Vos T, Haby MM, Barendregt JJ, et al. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004;61:1097-103.
40. Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 1999;319:1423-5.
41. Murray CJ, Salomon JA, Mathers C. A critical examination of summary measures of population health. Bull World Health Organ 2000;78:981-94.
42. Daniels N. Distributive justice and the use of summary measures of population health status. In: Field M, Gold G, eds. Summarizing population health: directions for the development and application of population metrics. Washington DC: National Academy Press, 1998.
43. van der Maas PJ. How summary measures of population health are affecting health agendas. Bull World Health Organ 2003;81:314.